6/24/2011

Sen. Al Franken, D-Minn., sent a letter to Dr. Jeffrey Shuren, director of the FDA's device center, calling on the agency to seek comments from the U.S. medical device industry before making any changes to the 510(k) clearance process.

Related Summaries